Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. - Wikidata - awgldk - TriplyDB

Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.

Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q33391370

about

The complotype: dictating risk for inflammation and infection Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases.A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.Affinity purification of human factor H on polypeptides derived from streptococcal m protein: enrichment of the Y402 variant Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3 Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.Complement Dysregulation and Disease: Insights from Contemporary Genetics.Annexin A2 Enhances Complement Activation by Inhibiting Factor H Sequence and Expression of Complement Factor H Gene Cluster Variants and Their Roles in Age-Related Macular Degeneration Risk.Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment.Neisseria meningitidis B vaccines: recent advances and possible immunization policies.Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.A novel, multiplexed targeted mass spectrometry assay for quantification of complement factor H (CFH) variants and CFH-related proteins 1-5 in human plasma.Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma.FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.Complement in cancer: untangling an intricate relationship.Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation.Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of CFHR4.

P2860

Q26862665-B206625A-8ABC-4DD3-9832-85207BC74C1E Q33404888-32AE7E93-0123-4317-B8C6-6114EFE74EB0 Q33425911-81AF64C2-EA85-4C57-966F-598D78E6F817 Q33426927-72CCA06C-2366-44F7-98FF-EB0054D2D0FA Q35053992-7CD0E48A-6112-49D9-87BE-E9E1FE4A3114 Q35967438-08672A85-72BC-41C9-BA11-F3F299E5BDF7 Q36182912-DF07E24F-6D61-4208-A7CD-AD2758319B00 Q36221928-2DA90C91-2E92-47E9-BE6F-F92A984E9EFD Q36495141-7145ABF8-0A90-4719-AB95-988748AC2392 Q36944530-3E0178DF-152C-4068-853E-69F2ED8A7D84 Q37563002-B1DEF807-605D-448C-9D95-65AA652D2FCF Q38183156-00F85A5A-056D-4F7B-9746-39B8E9783A96 Q38223669-6145E506-6E57-4235-8E4F-F67D7238DDD6 Q39447009-3D6B5EAB-8942-4AC5-AB54-B6C75788ED6C Q40574092-FDA199FF-9830-442B-A42F-A2E711643C48 Q47111288-274CAD18-93A5-45D1-8782-019FD59A5C5E Q48113964-4070D479-4B44-40CC-B9D3-4B9CDDF67FDA Q50049007-E77A2FA4-EE7F-49FE-AF53-4E659C3753A9 Q51353137-557DBDE4-8A8F-4C16-A1EB-4CFD9CF4403A Q55261422-A41D1BC4-E9AD-4039-AF6C-3E53D8CB566A

P2860

Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q33391370

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Variant-specific quantificatio ...... cal hemolytic uremic syndrome.

@ast

Variant-specific quantificatio ...... cal hemolytic uremic syndrome.

@en

type

label

Variant-specific quantificatio ...... cal hemolytic uremic syndrome.

@ast

Variant-specific quantificatio ...... cal hemolytic uremic syndrome.

@en

prefLabel

Variant-specific quantificatio ...... cal hemolytic uremic syndrome.

@ast

Variant-specific quantificatio ...... cal hemolytic uremic syndrome.

@en

P1433

Q33391370-CD77FDF1-9197-4E15-89D6-A334A9BD5046

P1476

Q33391370-0FF41F46-360D-4860-9AF8-3DA7B1D0E168

P2093

Q33391370-BA7E9541-33CF-4053-8D56-CD4542E88643

Q33391370-CCCE310F-AF40-44C2-9B34-5016DA484DC2

Q33391370-E2C7163D-7007-4790-8E89-344AD66BF0E0

P2860

Q33391370-02C38624-567D-469C-A5BD-A4F3DF8CCCC5

Q33391370-0DACC696-895D-4DA8-89FE-831ED7814821

Q33391370-20E69829-1095-48C1-9854-BA82072599DB

Q33391370-25C76CDB-C668-41D9-8E12-2A1B2690068A

Q33391370-26B057EF-8CFB-4CC5-86A5-5A307E1697DD

Q33391370-2F1A064B-BB9F-4106-9612-800F083482AC

Q33391370-31DB14B6-5F57-4B8C-9696-3BFE3CF7DCD9

Q33391370-3F60919A-0F69-414B-B27F-8318AB58E30F

Q33391370-42147322-570C-4B79-A823-DE3680F69DEB

Q33391370-49CD6E33-6F8A-49E9-B6FF-DBB138B42660

P2888

Q33391370-82D66401-CF2B-4FA5-B4DF-F134A5DA3B45

P304

Q33391370-8C8A1E98-25F0-4FB8-88E6-4777CD074BDA

P31

Q33391370-CDCD75FC-C0E8-44DD-A600-DCDCF7FA60A9

P356

Q33391370-40A381ED-04B2-41C4-AC6F-359CCF477267

P407

Q33391370-00303033-BF15-4F58-9CE8-CA1EFB23F5AE

P433

Q33391370-55A6DAED-C445-449D-9114-89607D17E3CF

P478

Q33391370-2894B655-A326-4797-B511-ACD5EC548BCC

P50

Q33391370-11EBFDD1-817C-41B8-BB64-34387E530042

Q33391370-83713D2D-BB06-4243-85ED-75C5666520A5

P577

Q33391370-DDA54AA1-3336-431E-B158-7707C62FEF67

P5875

Q33391370-1A17BCF6-3D1D-4E82-BCC3-E48D16F4018F

P6179

Q33391370-C90133DC-92EF-4EF8-82EC-F7D8A4D1B2D5

P698

Q33391370-0B95A452-614C-4393-B2A6-1CAAA33D0D45

P932

Q33391370-8ABE7A8E-D741-40E5-92BD-78F75A6ED5BB

P356

P1433

Kidney International

P1476

Variant-specific quantificatio ...... cal hemolytic uremic syndrome.

@en

P2093

Bryan P Morgan

http://www.w3.org/2001/XMLSchema#string

Claire L Harris

http://www.w3.org/2001/XMLSchema#string

Svetlana Hakobyan

http://www.w3.org/2001/XMLSchema#string

P2860

Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism

The human complement factor H: functional roles, genetic variations and disease associations

The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration

Complement factor H polymorphism and age-related macular degeneration

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy.

Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.

Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period.

The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.

P2888

P304

782-788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2010.275

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Santiago Rodriguez de Córdoba

Agustín Tortajada

P577

2010-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45630109

http://www.w3.org/2001/XMLSchema#string

P6179

1050553462

http://www.w3.org/2001/XMLSchema#string

P698

20703214

http://www.w3.org/2001/XMLSchema#string

P932

3252682

http://www.w3.org/2001/XMLSchema#string